Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 143 (1) , 104-113.e14
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthmaJournal of Allergy and Clinical Immunology, 2018
- Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent ExacerbationsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Biomarkers of Airway Type-2 Inflammation and Integrating Complex Phenotypes to Endotypes in AsthmaCurrent Allergy and Asthma Reports, 2016
- Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohortsThe Lancet Respiratory Medicine, 2016
- The effects of corticosteroids on cytokine production from asthma lung lymphocytesInternational Immunopharmacology, 2014
- Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthmaJournal of Allergy and Clinical Immunology, 2014
- Interleukin-13 inhibits proliferation and enhances contractility of human airway smooth muscle cells without change in contractile phenotypeAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- The RIN: an RNA integrity number for assigning integrity values to RNA measurementsBMC Molecular Biology, 2006
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation.2000
- Comparison of two methods of collecting induced sputum in asthmatic subjectsEuropean Respiratory Journal, 1996